Wealthcare Advisory Partners LLC Grows Stock Position in Colgate-Palmolive (NYSE:CL)

Wealthcare Advisory Partners LLC boosted its holdings in shares of Colgate-Palmolive (NYSE:CL) by 4.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,009 shares of the company’s stock after acquiring an additional 162 shares during the quarter. Wealthcare Advisory Partners LLC’s holdings in Colgate-Palmolive were worth $364,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CL. Avanza Fonder AB purchased a new position in shares of Colgate-Palmolive during the fourth quarter worth $7,944,000. First Pacific Financial boosted its holdings in Colgate-Palmolive by 326.1% during the 4th quarter. First Pacific Financial now owns 1,960 shares of the company’s stock valued at $178,000 after acquiring an additional 1,500 shares during the period. Goldstone Financial Group LLC grew its position in Colgate-Palmolive by 14.4% in the 4th quarter. Goldstone Financial Group LLC now owns 6,210 shares of the company’s stock valued at $565,000 after acquiring an additional 781 shares in the last quarter. Ritholtz Wealth Management increased its stake in Colgate-Palmolive by 11.6% during the fourth quarter. Ritholtz Wealth Management now owns 68,745 shares of the company’s stock worth $6,250,000 after purchasing an additional 7,123 shares during the period. Finally, Hennion & Walsh Asset Management Inc. lifted its position in shares of Colgate-Palmolive by 1.7% during the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 21,342 shares of the company’s stock worth $1,940,000 after purchasing an additional 367 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.37% of the stock is owned by insiders.

Colgate-Palmolive Trading Up 0.3 %

Shares of Colgate-Palmolive stock opened at $88.79 on Tuesday. The business has a fifty day simple moving average of $92.20 and a 200-day simple moving average of $97.76. The firm has a market cap of $72.55 billion, a price-to-earnings ratio of 25.44, a price-to-earnings-growth ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $79.69 and a fifty-two week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.25%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on CL. TD Cowen dropped their price target on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. Barclays lowered their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research note on Friday. JPMorgan Chase & Co. reduced their price target on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research report on Thursday, January 16th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Finally, UBS Group reduced their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.